Reawakening retrotransposons: immune modulation in normal and malignant hematopoiesis
Trends in Cancer · 2025
DOI: 10.1016/j.trecan.2025.07.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Cancer, 2025. Verfasst von Hale Tunbak und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK; QMUL Centre for Epigenetics, Queen Mary University …. Hauptthemen laut MEDLINE: Retroelements, Hematopoiesis, Hematologic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Research and Innovation, Cancer Research UK.
Abstract (Originalsprache)
Retrotransposons are mobile repetitive elements that constitute around 43% of the human genome. Normally silenced through epigenetic mechanisms, retrotransposons can become reactivated in response to various stimuli, producing immunogenic DNA, RNA, and peptides that trigger innate and adaptive immune responses. In normal hematopoiesis, retrotransposon reactivation can drive inflammatory signaling responses, which support stem cell activity, influencing hematopoietic stem and progenitor cell (HSPC) regeneration. In hematological cancers, their reactivation can alter the tumor microenvironment and promote immune evasion. Here, we highlight the complex interactions between retrotransposons, hematopoiesis, and immune modulation. We also emphasize the therapeutic potential of targeting retrotransposons, while addressing critical knowledge gaps in retrotransposon-driven immune modulation across both health and disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK; QMUL Centre for Epigenetics, Queen Mary University of London, London, UK. Electronic address: h.tunbak@qmul.ac.uk.
- Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK; QMUL Centre for Epigenetics, Queen Mary University of London, London, UK. Electronic address: o.deniz@qmul.ac.uk.
Förderung
- UK Research and Innovation
- Cancer Research UK
Zitieren
APA
Tunbak, H., & Deniz, Ö. (2025). Reawakening retrotransposons: immune modulation in normal and malignant hematopoiesis. Trends in Cancer. https://doi.org/10.1016/j.trecan.2025.07.006
Vancouver
Tunbak H, Deniz Ö. Reawakening retrotransposons: immune modulation in normal and malignant hematopoiesis. Trends in Cancer. 2025. doi:10.1016/j.trecan.2025.07.006
BibTeX
@article{Tunbak2025,
author = {Tunbak, Hale and Deniz, Özgen},
title = {Reawakening retrotransposons: immune modulation in normal and malignant hematopoiesis},
journal = {Trends in Cancer},
year = {2025},
doi = {10.1016/j.trecan.2025.07.006}
}
EUVIMED